Factors delaying intravenous thrombolytic therapy in acute ischaemic stroke: a systematic review of the literature.
Angelos SharobeamBrett JonesDianne Walton-SondaChristian J LueckPublished in: Journal of neurology (2020)
Further integrated processes are required to maximise patient benefit from thrombolysis. Expansion of community education to incorporate less common symptoms and provision of alert pagers for patients may provide further reduction in thrombolysis times.
Keyphrases
- pulmonary embolism
- acute ischemic stroke
- end stage renal disease
- healthcare
- ejection fraction
- newly diagnosed
- case report
- peritoneal dialysis
- high dose
- mesenchymal stem cells
- quality improvement
- low dose
- clinical decision support
- cell therapy
- acute respiratory distress syndrome
- sleep quality
- extracorporeal membrane oxygenation